Open to all conference attendees.

The 340B program has grown into a powerful force shaping drug pricing and access, with significant downstream effects for employer-sponsored plans. As the 340B program continues to evolve, employers are increasingly affected by its impact on drug pricing, plan costs, and employee access to care. This session brings together industry experts and employer leaders to unpack how 340B shapes the commercial market, what it means for pharmacy benefit strategies, and how employers can leverage their influence to drive greater transparency and value.